Reports for CANDESARTAN CILEXETIL
Ingredient
CANDESARTAN CILEXETIL
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195557 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2024-01-25 | 2024-02-08 | 217237 |
TEVA-CANDESARTAN | 32MG | TABLET | Actual shortage | 2024-03-28 | 2024-06-13 | 223853 |
TARO-CANDESARTAN | 32MG | TABLET | Resolved | 2019-05-28 | 2021-01-31 | 85078 |
TARO-CANDESARTAN | 32MG | TABLET | Resolved | 2022-08-25 | 2023-09-26 | 167932 |
ACH-CANDESARTAN | 32MG | TABLET | Resolved | 2019-11-25 | 2020-06-05 | 99615 |
ACH-CANDESARTAN | 32MG | TABLET | Resolved | 2022-05-26 | 2022-12-19 | 161337 |
ACH-CANDESARTAN | 32MG | TABLET | Resolved | 2023-05-05 | 2023-06-17 | 191757 |
ACH-CANDESARTAN | 32MG | TABLET | Resolved | 2023-07-21 | 2023-11-03 | 199644 |
ACH-CANDESARTAN | 32MG | TABLET | Actual shortage | 2024-01-26 | 2024-01-27 | 217363 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
MYLAN-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53621 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |